Short pages

Jump to navigation Jump to search

Showing below up to 50 results in range #13,981 to #14,030.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Gender-neutral [321 bytes]
  2. (hist) CBD [321 bytes]
  3. (hist) Circulation time [321 bytes]
  4. (hist) Neurocardiogenic syncope physical examination [321 bytes]
  5. (hist) Arthrogryposis (patient information) [321 bytes]
  6. (hist) Amenorrhea cost-effectiveness of therapy [321 bytes]
  7. (hist) Amenorrhea future or investigational therapies [321 bytes]
  8. (hist) Melanoma case study one [321 bytes]
  9. (hist) Bradycardia MRI [321 bytes]
  10. (hist) Polyarteritis nodosa screening [321 bytes]
  11. (hist) Pancreatic pseudocyst secondary prevention [321 bytes]
  12. (hist) Hypomagnesemia cost-effectiveness of therapy [321 bytes]
  13. (hist) Microangiopathic hemolytic anemia primary prevention [321 bytes]
  14. (hist) Idiopathic thrombocytopenic purpura differential diagnosis [321 bytes]
  15. (hist) Petechia historical perspective [321 bytes]
  16. (hist) Petechia differential diagnosis [321 bytes]
  17. (hist) Petechia epidemiology and demographics [321 bytes]
  18. (hist) Petechia risk factors [321 bytes]
  19. (hist) Petechia natural history, complications and prognosis [321 bytes]
  20. (hist) Petechia history and symptoms [321 bytes]
  21. (hist) Petechia laboratory findings [321 bytes]
  22. (hist) Petechia other diagnostic studies [321 bytes]
  23. (hist) Petechia medical therapy [321 bytes]
  24. (hist) Petechia primary prevention [321 bytes]
  25. (hist) Petechia secondary prevention [321 bytes]
  26. (hist) Petechia future or investigational therapies [321 bytes]
  27. (hist) Pleurisy cost-effectiveness of therapy [321 bytes]
  28. (hist) Drug-induced lupus erythematosus risk factors [321 bytes]
  29. (hist) Polycystic kidneys, severe infantile, with tuberous sclerosis [321 bytes]
  30. (hist) Bacterial vaginosis cost-effectiveness of therapy [321 bytes]
  31. (hist) Amaurosis fugax secondary prevention [321 bytes]
  32. (hist) Cervicitis staging [321 bytes]
  33. (hist) Atherosclerosis physical examination [321 bytes]
  34. (hist) Atherosclerosis other diagnostic studies [321 bytes]
  35. (hist) Atherosclerosis primary prevention [321 bytes]
  36. (hist) Atherosclerosis secondary prevention [321 bytes]
  37. (hist) Atherosclerosis cost-effectiveness of therapy [321 bytes]
  38. (hist) Atherosclerosis case study one [321 bytes]
  39. (hist) Malabsorption risk factors [321 bytes]
  40. (hist) Constrictive pericarditis case study one [321 bytes]
  41. (hist) Ancylostomiasis other imaging findings [321 bytes]
  42. (hist) 11β-hydroxylase deficiency other imaging findings [321 bytes]
  43. (hist) Chronic diarrhea future or investigational therapies [321 bytes]
  44. (hist) Gastrointestinal perforation primary prevention [321 bytes]
  45. (hist) Renal tubular acidosis echocardiography and ultrasound [321 bytes]
  46. (hist) Spinal stenosis electrocardiogram [321 bytes]
  47. (hist) Angiomyolipoma electrocardiogram [321 bytes]
  48. (hist) Constrictive pericarditis primary prevention [321 bytes]
  49. (hist) Mannose-binding protein-associated serine protease [322 bytes]
  50. (hist) Dimiter Orahovats [322 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)